Cohort studies of cardiovascular disease in the Seychelles, Tanzania and Mauritius

Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Assessment of preoperative pro-BNP levels in patients with rheumatic heart disease with normal left ventricular function; Institute of Cardiovascular Diseases. et al. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation. brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. Congestive heart failure after surgical correction of mitral regurgitation. A long-term study. Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes. Pulsed tissue Doppler imaging detects early myocardial dysfunction in asymptomatic patients with severe mitral regurgitation. Usefulness of systolic excursion of the mitral anulus as an index of left ventricular systolic function. Mitral valve repair versus replacement for isolated non-ischemic mitral regurgitation in patients with preoperative left ventricular dysfunction. A long-term follow-up echocardiography study. Ballman KV, et al. Atrial fibrillation after surgical correction of mitral regurgitation in sinus rhythm: incidence, outcome, and determinants. Prospective validation of the prog-nostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. Avierinos JF, et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. cohort studies of cardiovascular disease in the seychelles, tanzania and Mauritius We read with interest the review by Kengne et al. on cohort studies of cardiovascular disease in sub-Sahara Africa. 1 We agree with the authors that cohort studies are important tools to advance our knowledge of cardiovascular disease in the region and inform appropriate clinical and public health responses. We recognise the difficult challenge of identifying all cohort studies in the region. We wish however to mention several cohort studies in the Seychelles, Tanzania and Mauritius, which were published in leading medical journals but were not included in the review, although they met inclusion criteria set by the authors of the review. The Republic of Seychelles, which lies in the Indian Ocean around 1 000 km east of Kenya, belongs to south Saharan Africa. Seychelles is part of WHO AFRO, is a member of the South African Development Community (SADEC) and contributes epidemiological data to the Global Burden of Disease project for estimates of the east Africa region. The majority of the population of Seychelles is of African descent. In a cohort study of 5 514 Seychelles …